Literature DB >> 29916740

Preserving Skin Integrity with Chronic Device Use in Diabetes.

Laurel H Messer1, Cari Berget1, Christie Beatson1, Sarit Polsky1, Gregory P Forlenza1.   

Abstract

Skin integrity and diabetes device placement are ongoing concerns for people with diabetes who utilize continuous glucose monitors (CGMs) and continuous subcutaneous insulin infusion pumps. This is especially significant for individuals with skin sensitivities, pediatric patients, and those who use devices chronically. Dermatological complications are often cited as a barrier to device use and a reason for device discontinuation. Furthermore, it is a frequent topic of discussion in diabetes follow-up visits, although little evidence-based literature exists to guide providers in managing skin integrity issues. The purpose of this article is to review current literature related to the prevalence of dermatological issues with insulin pumps and CGM, discuss published solutions to skin irritation, and to share the consolidated experience of our large academic diabetes clinic to address placement, prophylactic skin care, adhesives, removal, and skin healing with diabetes device use. Recommendations for targeted studies, increased surveillance, and development of new adhesive compounds are suggested to reduce the burden of device wear for management of diabetes.

Entities:  

Keywords:  CGM; CSII; Dermatitis; Diabetes; Hypersensitivity; Skin care

Mesh:

Substances:

Year:  2018        PMID: 29916740      PMCID: PMC6011799          DOI: 10.1089/dia.2018.0080

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  34 in total

1.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

2.  Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus.

Authors:  Simone Faccioli; Simone Del Favero; Roberto Visentin; Riccardo Bonfanti; Dario Iafusco; Ivana Rabbone; Marco Marigliano; Riccardo Schiaffini; Daniela Bruttomesso; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2017-05-09

Review 3.  Adverse effects of topical glucocorticosteroids.

Authors:  Ulrich R Hengge; Thomas Ruzicka; Robert A Schwartz; Michael J Cork
Journal:  J Am Acad Dermatol       Date:  2006-01       Impact factor: 11.527

4.  Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.

Authors:  E Binder; O Lange; M Edlinger; D Meraner; D Abt; C Moser; E Steichen; S E Hofer
Journal:  Exp Clin Endocrinol Diabetes       Date:  2015-01-21       Impact factor: 2.949

5.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

Review 6.  Skin-related complications of insulin therapy: epidemiology and emerging management strategies.

Authors:  Tristan Richardson; David Kerr
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

7.  Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries.

Authors:  Laurie McNichol; Carolyn Lund; Ted Rosen; Mikel Gray
Journal:  J Wound Ostomy Continence Nurs       Date:  2013 Jul-Aug       Impact factor: 1.741

8.  Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes.

Authors:  Daniel J DeSalvo; David M Maahs; Laurel Messer; R Paul Wadwa; Shelby Payne; Trang T Ly; Bruce A Buckingham
Journal:  Diabetes Care       Date:  2015-08-25       Impact factor: 19.112

9.  Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.

Authors:  Denice S Feig; Lois E Donovan; Rosa Corcoy; Kellie E Murphy; Stephanie A Amiel; Katharine F Hunt; Elizabeth Asztalos; Jon F R Barrett; J Johanna Sanchez; Alberto de Leiva; Moshe Hod; Lois Jovanovic; Erin Keely; Ruth McManus; Eileen K Hutton; Claire L Meek; Zoe A Stewart; Tim Wysocki; Robert O'Brien; Katrina Ruedy; Craig Kollman; George Tomlinson; Helen R Murphy
Journal:  Lancet       Date:  2017-09-15       Impact factor: 79.321

10.  A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Authors:  Lori M Laffel; Grazia Aleppo; Bruce A Buckingham; Gregory P Forlenza; Lisa E Rasbach; Eva Tsalikian; Stuart A Weinzimer; Dennis R Harris
Journal:  J Endocr Soc       Date:  2017-11-20
View more
  17 in total

1.  Five-Month Follow-up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps.

Authors:  Anna T Weng; Claus Zachariae; Karl B Christensen; Jannet Svensson; Anna K Berg
Journal:  J Diabetes Sci Technol       Date:  2019-10-16

2.  A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.

Authors:  Laurel H Messer; Cari Berget; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2019-05-29       Impact factor: 6.118

3.  A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.

Authors:  Cari Berget; Laurel H Messer; Gregory P Forlenza
Journal:  Diabetes Spectr       Date:  2019-08

4.  Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies.

Authors:  Nurul A Mohd Asarani; Andrew N Reynolds; Sara E Boucher; Martin de Bock; Benjamin J Wheeler
Journal:  J Diabetes Sci Technol       Date:  2019-08-27

5.  Analysis of "Accuracy of a 14-Day Factory Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes".

Authors:  Tejaswi Kompala; Aaron B Neinstein
Journal:  J Diabetes Sci Technol       Date:  2020-10-21

6.  High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.

Authors:  Fortunato Lombardo; Stefano Passanisi; Davide Tinti; Maria Francesca Messina; Giuseppina Salzano; Ivana Rabbone
Journal:  J Diabetes Sci Technol       Date:  2020-08-06

7.  Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.

Authors:  Molly L Tanenbaum; Laurel H Messer; Christine A Wu; Marina Basina; Bruce A Buckingham; Danielle Hessler; Shelagh A Mulvaney; David M Maahs; Korey K Hood
Journal:  Diabetes Res Clin Pract       Date:  2021-09-14       Impact factor: 8.180

8.  Assessment of a Noninvasive Chronic Glucose Monitoring System in Euglycemic and Diabetic Swine (Sus scrofa).

Authors:  Rebecca A Ober; Gail E Geist
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-04-13       Impact factor: 1.232

9.  MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.

Authors:  Aria Saunders; Laurel H Messer; Gregory P Forlenza
Journal:  Expert Rev Med Devices       Date:  2019-09-30       Impact factor: 3.166

Review 10.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Authors:  Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.